Instituto de Medicina Molecular

The Instituto de Medicina Molecular João Lobo Antunes (Institute of Molecular Medicine), or iMM for short, is an associated research institution of the University of Lisbon, in Lisbon, Portugal.

IMM is devoted to human genome research with the aim of contributing to a better understanding of disease mechanisms, developing novel predictive tests, improving diagnostics tools, and developing new therapeutic approaches.

[citation needed] In 2003, the Molecular Pathobiology Research Centre (CIPM) of the Portuguese Institute of Oncology Francisco Gentil (IPOFG) became an associate member of IMM.

[citation needed] Historically, IMM benefited from the full integration of academic researchers into the Lisbon Medical School who initiated their academic training and scientific careers at Instituto Gulbenkian de Ciência (IGC), in Oeiras, one of the first national institutions to introduce and make use of state-of-the-art cell and molecular biology techniques.

[citation needed] The IMM is now known as Instituto de Medicina Molecular João Lobo Antunes, to honour one of its founders and president (2001-2014), Professor João Lobo Antunes.